ProCE Banner Activity


Practical Strategies for Applying Evidence and Patient Perspectives to Improve Obesity Management: Identifying the Right Treatment for the Right Patient


Experts discuss the importance of weight loss in reducing long-term complications of obesity and factors to consider when developing a treatment plan for patients with obesity.

ABIM MOC: maximum of 0.50 Medical Knowledge MOC point

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: January 25, 2024

Expiration: January 24, 2025



Jaime Almandoz

Jaime Almandoz, MD, MBA, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

Angela Golden

Angela Golden, DNP, FNP-C, FAANP, FOMA

CEO and Chief Clinical Officer 
NP From Home, LLC 
Munds Park, Arizona 
Nurse Practitioner  
Obesity Treatment Clinic
Flagstaff, Arizona

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinician Exchange, Obesity Medicine Association and Smart Patients

ProCE Banner


Supported by an educational grant from Lilly.



Obesity Medicine Association

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Smart Patients

ProCE Banner

Target Audience

US primary care physicians, NPs, and PAs

Program Learning Goal

The goal of this program is to improve the knowledge, competence, and performance of learners in prioritizing obesity management, identifying patients who could benefit from pharmacologic treatment, and engaging patients in nonbiased discussions to achieve effective and sustained weight loss.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply tactics to patient care that demonstrate the value of prioritizing weight loss to reduce the risk of long-term complications from obesity-related comorbidities

  • Develop pharmacologic treatment plans for patients with obesity based on individual patient needs and preferences

  • Evaluate the effectiveness of strategies for engaging patients in successful long-term weight loss in the management of obesity


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Program Director

Jaime Almandoz, MD, MBA, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

Jaime Almandoz, MD, MBA, FTOS: consultant/advisor/speaker: Lilly, Novo Nordisk.

Angela Golden, DNP, FNP-C, FAANP, FOMA

CEO and Chief Clinical Officer 
NP From Home, LLC 
Munds Park, Arizona 
Nurse Practitioner  
Obesity Treatment Clinic
Flagstaff, Arizona

Angela Golden, DNP, FNP-C, FAANP, FOMA: consultant/advisor/speaker: Acella, Currax, Gelesis, Lilly, Novo Nordisk, SetPoint.

The planners and content peer reviewers from Clinical Care Options, LLC, Practicing Clinicians Exchange, Smart Patients, and the Obesity Medicine Association do not have any relevant financial relationships to disclose, except Nicolas Pennings, DO, and Amy Butts, PA-C as noted below:

Nicolas Pennings, DO: consultant/advisor/speaker: Gelesis, Lilly, Novo Nordisk; independent contractor: Medifast.

Amy Butts, PA-C: consultant/advisor/speaker: Abbott, Bayer, Novo Nordisk, Sanofi.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 25, 2024, through January 24, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and Smart Patients. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until January 24, 2025. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification 

A blue and white signDescription automatically generated with low confidence

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).